Literature DB >> 10906057

Leukemia inhibitory factor, leukemia inhibitory factor receptor, and glycoprotein 130 in rhesus monkey uterus during menstrual cycle and early pregnancy.

Z P Yue1, Z M Yang, P Wei, S J Li, H B Wang, J H Tan, M J Harper.   

Abstract

This goal of this study was to examine immunohistochemical distribution of leukemia inhibitory factor (LIF), LIF receptor (LIFR), and glycoprotein (gp) 130 in rhesus monkey uterus during the menstrual cycle and early pregnancy. Pregnancy rate was significantly reduced in the control group from 66.7% (12 of 18) to 22.2% (4 of 18) with an injection of goat anti-human recombinant LIF immunoglobulin G into the uterine lumen on Day 8 of pregnancy. LIF was mainly localized in glandular and luminal epithelium. LIF immunostaining during the luteal phase was stronger than it was during the proliferative phase. LIF staining gradually increased from Day 3 of pregnancy and reached its highest level on Day 9. LIFR was mainly localized in the glandular and luminal epithelium. LIFR staining during the luteal phase was stronger than it was during the proliferative phase. LIFR staining began to increase from Day 3 of pregnancy and reached a high level on Days 9 and 11. Gp130, a signal-transducing receptor component of LIF, was mainly localized in the glandular epithelium. A high level of gp130 was found on Days 16 and 20 of menstrual cycle, and from Days 5 to 11 of pregnancy. These results suggest that LIF may play an important role in monkey implantation, as it does in mice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10906057     DOI: 10.1095/biolreprod63.2.508

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  18 in total

Review 1.  Control of uterine receptivity and embryo implantation by steroid hormone regulation of LIF production and LIF receptor activity: towards a molecular understanding of "the window of implantation".

Authors:  Jr-Gang Cheng; Clara I Rodriguez; Colin L Stewart
Journal:  Rev Endocr Metab Disord       Date:  2002-05       Impact factor: 6.514

2.  Dual control of LIF expression and LIF receptor function regulate Stat3 activation at the onset of uterine receptivity and embryo implantation.

Authors:  J G Cheng; J R Chen; L Hernandez; W G Alvord; C L Stewart
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

Review 3.  As the world grows: contraception in the 21st century.

Authors:  R John Aitken; Mark A Baker; Gustavo F Doncel; Martin M Matzuk; Christine K Mauck; Michael J K Harper
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

Review 4.  Endometrial responses to embryonic signals in the primate.

Authors:  Prajna Banerjee; Asgerally T Fazleabas
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

Review 5.  The evolution of embryo implantation.

Authors:  Michael R McGowen; Offer Erez; Roberto Romero; Derek E Wildman
Journal:  Int J Dev Biol       Date:  2014       Impact factor: 2.203

6.  MicroRNA-223-3p suppresses leukemia inhibitory factor expression and pinopodes formation during embryo implantation in mice.

Authors:  Xiyuan Dong; Cong Sui; Kai Huang; Lan Wang; Dan Hu; Ting Xiong; Rui Wang; Hanwang Zhang
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

7.  Inhibition of Stat3 activation in the endometrium prevents implantation: a nonsteroidal approach to contraception.

Authors:  Rob D Catalano; Martin H Johnson; Elizabeth A Campbell; D Stephen Charnock-Jones; Stephen K Smith; Andrew M Sharkey
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-03       Impact factor: 11.205

Review 8.  Extragonadal actions of chorionic gonadotropin.

Authors:  Prajna Banerjee; Asgerally T Fazleabas
Journal:  Rev Endocr Metab Disord       Date:  2011-12       Impact factor: 6.514

9.  Calcitonin immunostaining in monkey uterus during menstrual cycle and early pregnancy.

Authors:  Hong-Lu Diao; Shi-Jie Li; Hong-Bin Wang; Zeng-Ming Yang
Journal:  Endocrine       Date:  2002-06       Impact factor: 3.633

10.  Population pharmacokinetic modelling of Emfilermin (recombinant human leukaemia inhibitory factor, r-hLIF) in healthy postmenopausal women and in infertile patients undergoing in vitro fertilization and embryo transfer.

Authors:  Timothy Goggin; Quyen T X Nguyen; Alain Munafo
Journal:  Br J Clin Pharmacol       Date:  2004-05       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.